CKD

Aiosyn Launches Kidney Image Analysis Services Through Its NephroPath Platform to Accelerate Drug Development Studies

Retrieved on: 
Thursday, February 29, 2024

Aiosyn , a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, announced the introduction of its NephroPath platform .

Key Points: 
  • Aiosyn , a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, announced the introduction of its NephroPath platform .
  • By partnering with Aiosyn, CROs, biopharma, and researchers can accelerate the development of Chronic Kidney Disease (CKD) therapies using new and quantitative insights offered through Nephropath’s Kidney Image Analysis Services .
  • Through Nephropath’s Kidney Image Analysis Services, Aiosyn offers whole kidney quantification and custom kidney analyses.
  • “Using Aiosyn's NephroPath platform we provide researchers with a new and powerful technique to complement the CKD drug development toolbox,” said Patrick de Boer, CEO of Aiosyn.

Strive Health and Medical Mutual Partner to Bring Value-Based Kidney Care to Ohioans

Retrieved on: 
Tuesday, February 20, 2024

Denver-based Strive Health , the national leader in value-based kidney care, and Medical Mutual , one of the largest Ohio-based health insurance companies, have partnered to deliver value-based kidney care — which focuses on improving quality of care, provider performance and the patient experience — to eligible members with chronic kidney disease (CKD) and end-stage kidney disease.

Key Points: 
  • Denver-based Strive Health , the national leader in value-based kidney care, and Medical Mutual , one of the largest Ohio-based health insurance companies, have partnered to deliver value-based kidney care — which focuses on improving quality of care, provider performance and the patient experience — to eligible members with chronic kidney disease (CKD) and end-stage kidney disease.
  • View the full release here: https://www.businesswire.com/news/home/20240220840878/en/
    Through this partnership, Strive Health will bring value-based kidney care to Medical Mutual members in Ohio.
  • “Providing Medical Mutual members better access to value-based kidney care is an important step in achieving our mission to revolutionize kidney care through comprehensive, patient-centered solutions that improve the quality of life for those affected by CKD,” said Chris Riopelle, Co-Founder and CEO at Strive Health.
  • “We’ve seen great results with patients in slowing the progression of their kidney disease through our care model,” said Farhad Modarai, D.O., Chief Clinical Officer of Population Health at Strive Health.

New CDC Respiratory Guidance Ignores Kidney Patient Concerns

Retrieved on: 
Thursday, March 7, 2024

WASHINGTON, March 7, 2024 /PRNewswire/ -- Today, the American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, issued an Official Statement (appears below) in response to the Center for Disease Prevention and Control's (CDC) new Respiratory Virus Guidance, publicly announced on March 1, 2024. The CDC announcement occurred on the first day of National Kidney Month. March traditionally unites kidney stakeholders and people of goodwill in efforts to raise awareness of kidney diseases, address ongoing unmet patient needs, and advocate for removal of federal regulatory and payment barriers that impede access to, and development of, new kidney diagnostics, drugs, and devices.

Key Points: 
  • Mortality rates among kidney patients occurred at historic levels at the start of the COVID pandemic, devastated the kidney patient community and families, and this community's ongoing risks remain a strategic concern among patient advocates and allied kidney professionals.
  • AAKP also raised kidney patient health and safety concerns to CDC officials in stakeholder briefings prior to the March 1, 2024, CDC Respiratory Virus Guidance announcement.
  • The American Association of Kidney Patients (AAKP), the nation's largest and oldest independent kidney patient organization in the nation, is deeply concerned about the Center for Disease Prevention Control's (CDC) Respiratory Virus Guidelines, including for COVID, announced on March 1, 2024.
  • https://www.cdc.gov/mmwr/volumes/73/wr/mm7308a5.htm
    Since 1969, The American Association of Kidney Patients has been a patient-led organization driving policy discussions on kidney patient care choice and medical innovation.

Panoramic Health Launches Scientific Advisory Board to Accelerate Innovation in Kidney Care

Retrieved on: 
Thursday, March 7, 2024

TEMPE, Ariz., March 7, 2024 /PRNewswire/ -- Today, Panoramic Health, kidney care's leading integrated provider group, is proud to announce the establishment of its Scientific Advisory Board, a distinguished group of clinical leaders and research experts committed to advancing kidney care innovation. With a focus on uncovering and delivering cutting-edge treatments for patients with kidney disease, the advisory board will play a crucial role in guiding Panoramic Science, the company's clinical research division.

Key Points: 
  • TEMPE, Ariz., March 7, 2024 /PRNewswire/ -- Today, Panoramic Health, kidney care's leading integrated provider group, is proud to announce the establishment of its Scientific Advisory Board, a distinguished group of clinical leaders and research experts committed to advancing kidney care innovation.
  • "At Panoramic Health, we are dedicated to redefining the standard of kidney care through innovation and collaboration," said Dr. Rajiv Poduval, Co-Founder and Executive Chairman of Panoramic Health.
  • "Our Scientific Advisory Board brings together exceptional expertise that will drive our efforts to enhance patient care and transform the evolving landscape of kidney disease treatment.
  • Panoramic Health leadership team members serving on the advisory board include:
    The establishment of the Scientific Advisory Board underscores Panoramic Health's commitment to driving innovation and improving the lives of patients with kidney disease.

National Kidney Foundation Recognizes March as National Kidney Month

Retrieved on: 
Thursday, February 29, 2024

NEW YORK, Feb. 29, 2024 /PRNewswire/ -- As March approaches, the National Kidney Foundation (NKF) is gearing up to observe National Kidney Month, a crucial time dedicated to raising awareness about kidney health and chronic kidney disease (CKD). With World Kidney Day falling on Thursday, March 14th, this month holds particular significance in advocating for KIDNEY EQUITY FOR ALL™.

Key Points: 
  • NEW YORK, Feb. 29, 2024 /PRNewswire/ -- As March approaches, the National Kidney Foundation (NKF) is gearing up to observe National Kidney Month, a crucial time dedicated to raising awareness about kidney health and chronic kidney disease (CKD).
  • With World Kidney Day falling on Thursday, March 14th, this month holds particular significance in advocating for KIDNEY EQUITY FOR ALL™ .
  • "Despite this, they are exposed to inequities in kidney care including evaluation and obtaining a kidney transplant.
  • To mark National Kidney Month and World Kidney Day, NKF is highlighting several ways the organization is promoting kidney equity.

Evergreen Nephrology Names New Executive Leadership

Retrieved on: 
Thursday, February 29, 2024

NASHVILLE, Tenn., Feb. 29, 2024 /PRNewswire/ -- Today, Evergreen Nephrology announced the appointment of two key executives to its leadership team, Chief Financial Officer (CFO) Philip Cooksey and Chief Medical Officer (CMO), Dr. Tim Pflederer.

Key Points: 
  • NASHVILLE, Tenn., Feb. 29, 2024 /PRNewswire/ -- Today, Evergreen Nephrology announced the appointment of two key executives to its leadership team, Chief Financial Officer (CFO) Philip Cooksey and Chief Medical Officer (CMO), Dr. Tim Pflederer.
  • Evergreen Nephrology announces appointment of executives, Philip Cooksey, CFO and Dr. Tim Pflederer, CMO.
  • Evergreen also welcomes Dr. Tim Pflederer, MD, who will begin his role as CMO on April 1.
  • These efforts can significantly improve the quality of life for patients living among the 37 million adults with kidney disease in the U.S.
    "In partnership with nephrology practices across the country, Evergreen works to delay disease progression, decrease unnecessary hospitalizations, shift care to the home, and increase transplants for CKD patients," says, Adam Boehler, Executive Chairman of Evergreen Nephrology.

Avalon Saves Clients Millions, Sees Record Growth in 2023

Retrieved on: 
Tuesday, February 27, 2024

TAMPA, Fla., Feb. 27, 2024 /PRNewswire/ -- Avalon Healthcare Solutions, the world's first Lab Insights company, enjoyed record-setting growth in 2023 while helping its health insurer clients save money, improve operations, and ensure the highest quality care for their members. That year, Avalon clients realized approximately 10% to 20% savings on their outpatient lab spending across lines of business. Approximately 25% of those savings benefit member spending and member out-of-pocket costs.

Key Points: 
  • TAMPA, Fla., Feb. 27, 2024 /PRNewswire/ -- Avalon Healthcare Solutions , the world's first Lab Insights company, enjoyed record-setting growth in 2023 while helping its health insurer clients save money, improve operations, and ensure the highest quality care for their members.
  • That year, Avalon clients realized approximately 10% to 20% savings on their outpatient lab spending across lines of business.
  • Due to this emphasis, Avalon experienced record growth in 2023.
  • Also, in 2023, Avalon launched Precision Genetic Testing Management (PGTM), the next evolution of its genetic test management solution.

Healthy.io Expands Leadership Team, Appoints Becca LaFond as U.S. General Manager

Retrieved on: 
Tuesday, February 27, 2024

BOSTON, Feb. 27, 2024 /PRNewswire/ -- Healthy.io, the developer of the first and only FDA-cleared smartphone-powered at-home kidney test, today announced the appointment of Becca LaFond as the company's new U.S. General Manager.

Key Points: 
  • LaFond will work closely with Healthy.io partners to scale the commercialization of its Minuteful Kidney service while enhancing execution across payers, systems, and pharmaceutical companies.
  • LaFond brings over two decades of experience in the healthcare industry and expertise in optimizing operations through technology for better outcomes.
  • The addition of LaFond to Healthy.io's executive suite marks a continued expansion of its leadership team.
  • "We're excited to have Becca join the team to drive our next phase of expansion," said Healthy.io CEO Geoff Martin.

Pharmaceutical Patents Leader Duke Fitch Joins Troutman Pepper's National Health Sciences IP Team

Retrieved on: 
Wednesday, February 14, 2024

BERWYN, Pa., Feb. 14, 2024 /PRNewswire/ -- Duke Fitch, a leading patent practitioner in the pharmaceutical and biotech industries, has joined Troutman Pepper's Health Sciences Intellectual Property Practice Group as a partner in its Berwyn, Pennsylvania office. Fitch joins the firm after spending more than two decades with the global pharmaceutical company GSK, including in his most recent position as vice president of Pharmaceutical Patents U.S.

Key Points: 
  • Fitch Boosts Firm's Patents Capabilities in Pharma, Biotech Sectors
    BERWYN, Pa., Feb. 14, 2024 /PRNewswire/ -- Duke Fitch , a leading patent practitioner in the pharmaceutical and biotech industries, has joined Troutman Pepper's Health Sciences Intellectual Property Practice Group as a partner in its Berwyn, Pennsylvania office.
  • Fitch joins the firm after spending more than two decades with the global pharmaceutical company GSK, including in his most recent position as vice president of Pharmaceutical Patents U.S.
    At Troutman Pepper, Fitch will assist clients in the life sciences and health care space with their intellectual property needs including patent portfolio development and management, licensing, and dispute matters.
  • "Duke is a known leader in the pharmaceutical and biotech sectors, and his expertise in patents will benefit our clients in these industries and beyond," said Sean Fahey, chair of Troutman Pepper's Health Sciences Department.
  • Troutman Pepper's leading life sciences and health care practice counsels clients at all stages of the health care continuum – from drug development to clinical care – from emerging biotech to global pharma.

Dr. Lisandro Montalvo-Burke Joins Healthmap Solutions as Medical Director for Puerto Rico

Retrieved on: 
Tuesday, February 13, 2024

GUAYNABO, Puerto Rico, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), a leading kidney population health management company, has named Lisandro Montalvo-Burke, MD as its new Medical Director in Puerto Rico.

Key Points: 
  • GUAYNABO, Puerto Rico, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), a leading kidney population health management company, has named Lisandro Montalvo-Burke, MD as its new Medical Director in Puerto Rico.
  • Dr. Montalvo is a board-certified nephrologist and has been practicing nephrology in Canovanas, PR at his private practice since 2005.
  • He is a member of the American Society of Nephrology, Renal Physicians Association, National Kidney Foundation, and Sociedad de Nefrología e Hipertensión de Puerto Rico.
  • Healthmap has an all-star team here in Puerto Rico, and I am thrilled to be part of the organization.”